Innate Pharma S.A. ADS

IPHA
$1.75 -0.16 (-9.10%)
🚫 Innate Pharma S.A. ADS does not pay dividends

Company News

Arvind Sood joins Coherus Oncology as Chief Strategy and Corporate Affairs Officer
GlobeNewswire Inc. • Denny Lanfear • November 6, 2025

Coherus Oncology announced the appointment of Arvind Sood as Chief Strategy and Corporate Affairs Officer, focusing on advancing innovative cancer therapeutics and driving revenues for LOQTORZI®.

All You Need to Know About Innate Pharma (IPHA) Rating Upgrade to Buy
Zacks Investment Research • Zacks Equity Research • April 10, 2024

Innate Pharma (IPHA) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Why Shares of Innate Pharma Jumped Thursday
The Motley Fool • [email protected] (Jim Halley) • June 8, 2023

The company's collaboration agreement with Sanofi could soon pay off.

Why Shares of Chinese Companies Are Trading Higher? Here Are 55 Stocks Moving In Tuesday's Mid-Day Session
Benzinga • Lisa Levin • December 27, 2022

Gainers Elys Game Technology, Corp. (NASDAQ: ELYS) shares jumped 147% to $0.4312. Elys Game Technology and Cloakbook DC have been granted license to open sportsbook in Washington, D.C. 180 Life Sciences Corp. (NASDAQ: ATNF) climbed 71% to $2.12. 180 Life Sciences announced closing of $6 million registered direct offering priced at-the-market und...

Penny Stocks To Buy Now? 6 To Watch With Big News Today
PennyStocks • J. Samuel • December 19, 2022

Hot penny stocks to watch with big news this week. The post Penny Stocks To Buy Now? 6 To Watch With Big News Today appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Related Companies